Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance

Bacterial surface polysaccharides play significant roles in fitness and virulence. In Gram-negative bacteria such as Escherichia coli, major surface polysaccharides are lipopolysaccharide (LPS) and capsule, representing O- and K-antigens, respectively. There are multiple combinations of O:K types, m...

Full description

Bibliographic Details
Main Authors: Susan Harris, Marta J. Piotrowska, Robert J. Goldstone, Ruby Qi, Geoffrey Foster, Ulrich Dobrindt, Jean-Yves Madec, Charlotte Valat, Francesco V. Rao, David G. E. Smith
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.02026/full
id doaj-01ea173f77324b60a623daff796a3b33
record_format Article
spelling doaj-01ea173f77324b60a623daff796a3b332020-11-24T22:53:30ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2018-08-01910.3389/fmicb.2018.02026398160Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug ResistanceSusan Harris0Marta J. Piotrowska1Robert J. Goldstone2Ruby Qi3Geoffrey Foster4Ulrich Dobrindt5Jean-Yves Madec6Charlotte Valat7Francesco V. Rao8David G. E. Smith9Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, United KingdomInstitute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, United KingdomThe Francis Crick Institute, London, United KingdomInstitute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, United KingdomVeterinary Services, SAC Consulting, Scotland’s Rural College, Inverness, United KingdomInstitute of Hygiene, University of Münster, Münster, GermanyUnité Antibiorésistances et Virulences Bactériennes, Anses Laboratoire de Lyon, Université Lyon-1, Lyon, FranceUnité Antibiorésistances et Virulences Bactériennes, Anses Laboratoire de Lyon, Université Lyon-1, Lyon, FranceDC Biosciences Ltd., Dundee, United KingdomInstitute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, United KingdomBacterial surface polysaccharides play significant roles in fitness and virulence. In Gram-negative bacteria such as Escherichia coli, major surface polysaccharides are lipopolysaccharide (LPS) and capsule, representing O- and K-antigens, respectively. There are multiple combinations of O:K types, many of which are well-characterized and can be related to ecotype or pathotype. In this investigation, we have identified a novel O:K permutation resulting through a process of major genome reorganization in a clade of E. coli. A multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing strain – E. coli 26561 – represented a prototype of strains combining a locus variant of O89 and group 1 capsular polysaccharide. Specifically, the variant O89 locus in this strain was truncated at gnd, flanked by insertion sequences and located between nfsB and ybdK and we apply the term O89m for this variant. The prototype lacked colanic acid and O-antigen loci between yegH and hisI with this tandem polysaccharide locus being replaced with a group 1 capsule (G1C) which, rather than being a recognized E. coli capsule type, this locus matched to Klebsiella K10 capsule type. A genomic survey identified more than 200 E. coli strains which possessed the O89m locus variant with one of a variety of G1C types. Isolates from our collection with the combination of O89m and G1C all displayed a mucoid phenotype and E. coli 26561 was unusual in exhibiting a mucoviscous phenotype more recognized as a characteristic among Klebsiella strains. Despite the locus truncation and novel location, all O89m:G1C strains examined showed a ladder pattern typifying smooth LPS and also showed high molecular weight, alcian blue-staining polysaccharide in cellular and/or extra-cellular fractions. Expression of both O-antigen and capsule biosynthesis loci were confirmed in prototype strain 26561 through quantitative proteome analysis. Further in silico exploration of more than 200 E. coli strains possessing the O89m:G1C combination identified a very high prevalence of multidrug resistance (MDR) – 85% possessed resistance to three or more antibiotic classes and a high proportion (58%) of these carried ESBL and/or carbapenemase. The increasing isolation of O89m:G1C isolates from extra-intestinal infection sites suggests that these represents an emergent clade of invasive, MDR E. coli.https://www.frontiersin.org/article/10.3389/fmicb.2018.02026/fullEscherichia colinovel O-antigenlipopolysaccharidegroup 1 capsulemultidrug resistance (MDR)quantitative proteomics
collection DOAJ
language English
format Article
sources DOAJ
author Susan Harris
Marta J. Piotrowska
Robert J. Goldstone
Ruby Qi
Geoffrey Foster
Ulrich Dobrindt
Jean-Yves Madec
Charlotte Valat
Francesco V. Rao
David G. E. Smith
spellingShingle Susan Harris
Marta J. Piotrowska
Robert J. Goldstone
Ruby Qi
Geoffrey Foster
Ulrich Dobrindt
Jean-Yves Madec
Charlotte Valat
Francesco V. Rao
David G. E. Smith
Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance
Frontiers in Microbiology
Escherichia coli
novel O-antigen
lipopolysaccharide
group 1 capsule
multidrug resistance (MDR)
quantitative proteomics
author_facet Susan Harris
Marta J. Piotrowska
Robert J. Goldstone
Ruby Qi
Geoffrey Foster
Ulrich Dobrindt
Jean-Yves Madec
Charlotte Valat
Francesco V. Rao
David G. E. Smith
author_sort Susan Harris
title Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance
title_short Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance
title_full Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance
title_fullStr Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance
title_full_unstemmed Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance
title_sort variant o89 o-antigen of e. coli is associated with group 1 capsule loci and multidrug resistance
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2018-08-01
description Bacterial surface polysaccharides play significant roles in fitness and virulence. In Gram-negative bacteria such as Escherichia coli, major surface polysaccharides are lipopolysaccharide (LPS) and capsule, representing O- and K-antigens, respectively. There are multiple combinations of O:K types, many of which are well-characterized and can be related to ecotype or pathotype. In this investigation, we have identified a novel O:K permutation resulting through a process of major genome reorganization in a clade of E. coli. A multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing strain – E. coli 26561 – represented a prototype of strains combining a locus variant of O89 and group 1 capsular polysaccharide. Specifically, the variant O89 locus in this strain was truncated at gnd, flanked by insertion sequences and located between nfsB and ybdK and we apply the term O89m for this variant. The prototype lacked colanic acid and O-antigen loci between yegH and hisI with this tandem polysaccharide locus being replaced with a group 1 capsule (G1C) which, rather than being a recognized E. coli capsule type, this locus matched to Klebsiella K10 capsule type. A genomic survey identified more than 200 E. coli strains which possessed the O89m locus variant with one of a variety of G1C types. Isolates from our collection with the combination of O89m and G1C all displayed a mucoid phenotype and E. coli 26561 was unusual in exhibiting a mucoviscous phenotype more recognized as a characteristic among Klebsiella strains. Despite the locus truncation and novel location, all O89m:G1C strains examined showed a ladder pattern typifying smooth LPS and also showed high molecular weight, alcian blue-staining polysaccharide in cellular and/or extra-cellular fractions. Expression of both O-antigen and capsule biosynthesis loci were confirmed in prototype strain 26561 through quantitative proteome analysis. Further in silico exploration of more than 200 E. coli strains possessing the O89m:G1C combination identified a very high prevalence of multidrug resistance (MDR) – 85% possessed resistance to three or more antibiotic classes and a high proportion (58%) of these carried ESBL and/or carbapenemase. The increasing isolation of O89m:G1C isolates from extra-intestinal infection sites suggests that these represents an emergent clade of invasive, MDR E. coli.
topic Escherichia coli
novel O-antigen
lipopolysaccharide
group 1 capsule
multidrug resistance (MDR)
quantitative proteomics
url https://www.frontiersin.org/article/10.3389/fmicb.2018.02026/full
work_keys_str_mv AT susanharris varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT martajpiotrowska varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT robertjgoldstone varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT rubyqi varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT geoffreyfoster varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT ulrichdobrindt varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT jeanyvesmadec varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT charlottevalat varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT francescovrao varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
AT davidgesmith varianto89oantigenofecoliisassociatedwithgroup1capsulelociandmultidrugresistance
_version_ 1725663145799712768